期刊文献+

子宫浆液性癌与低分化子宫内膜样腺癌临床病理特征及预后比较 被引量:5

A Clinical Comparison between Uterine Serous Carcinom a and Grade3 Endometroid Endometrial Carcinomas
下载PDF
导出
摘要 目的:探讨子宫浆液性癌(USC)和低分化子宫内膜样腺癌(G3EEC)的临床病理特征和预后差异。方法:回顾性分析广东省子宫内膜癌防治项目2000年1月1日至2010年12月31日收治的101例USC患者和619例G3EEC患者,比较两者的临床、病理特征、免疫组化结果和预后。结果:1USC组和G3EEC组的发病年龄、未产、糖尿病、高血压、肥胖、首发症状(异常子宫出血)、临床分期Ⅲ或Ⅳ期比较,差异均无统计学意义(P>0.05);2手术病理分期Ⅲ或Ⅳ期、临床Ⅰ期术后分期升高、肿瘤局限于宫腔下部、深肌层浸润、腹水细胞学阳性、宫颈间质浸润、淋巴结转移以及大网膜转移比例比较,差异均无统计学意义(P>0.05);3雌激素受体、孕激素受体、人类表皮生长因子受体2阳性率比较,差异无统计学意义(P>0.05),USC组P53阳性率(86.2%)高于G3EEC组患者(53.4%),差异有统计学意义(P<0.05);45年总体生存率和无进展生存率,USC组患者分别为74.9%和67.9%,G3EEC组患者分别为78.4%和70.1%,差异无统计学意义(P>0.05)。结论:G3EEC患者与USC患者的临床病理特征和预后具有较多相似点,临床上应重视G3EEC的诊治与随访。 Objective: To compare the clinicopathological features and prognosis of patients with uterine serous carcinoma( USC) and grade3 endometrioid endometrial cancer( G3EEC). M ethods: 101 patients with USC and619 with G3 EEC who were included in a multicenter study of endometrial cancer prevention projects in Guangdong Province between 2000 and 2010 were retrospectively studied. Analysis was performed to compare their clinicopathological features and prognosis. Results: 1There were no significant differences in the mean age,proportion of nullparity,diabetes mellitus,hypertension,obesity and initial symptoms,clinical stage between two groups( P 〉0. 05). 2The proportion of advanced surgical stage,the patients with clinical stage Ⅰ who were upstaged after surgery,tumors confined to lower segment of uterus,deep myometrial invasion,positive washings,cervical stromal invasion,lymph node metastasis and omentum metastasis also featured no significant differences( P 〉0. 05). 3 No significant differences were found in estrogen receptor,progestrone receptor,human epidermal growth factor receptor 2 expression between USC and G3 EEC,while USC had a higher rate of P53 expression than G3EEC( 86. 2% vs 53. 4%,P〈0. 05). 4The 5-year overall survival for USC and G3 EEC were 74. 9% and78. 4%,respectively and 5-year progress free survival were 67. 9% and 70. 1%,respectively( P 〉0. 05). Conclusions: G3 EEC and USC share similar clinicopathological features and outcomes,so we should pay more attention to clinical diagnosis and treatment and follow-up of G3 EEC.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2016年第3期183-186,共4页 Journal of Practical Obstetrics and Gynecology
基金 国家自然科学基金(编号:30772332) 广东省自然科学基金(编号:S20120100086) 广东省妇幼安康工程-子宫内膜癌防治项目
关键词 子宫浆液性癌 低分化子宫内膜样腺癌 临床病理特征 Uterine serous carcinoma Grade 3 endometrioid endometrial carcinoma Clinicopathologic features
  • 相关文献

参考文献10

  • 1郑泽纯,李小毛.子宫浆液性腺癌的研究进展[J].实用医学杂志,2014,30(2):188-189. 被引量:2
  • 2Huang GS, Gebb JS, Einstein MH, et al. Accuracy of preoperative en- dometrial sampling for the detection of high-grade endometrial tumors [ J ]. Am J Obstet Gynecol,2007,196 ( 3 ) :241 - 243.
  • 3Ayeni TA, Bakkum-Gamez JN, Mariani A, et al. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell car- cinomas [ J ]. Gynecol Onco1,2013,129 ( 3 ) :478 - 485.
  • 4Alvarez T, Miller E, Duska L, et al. Molecular profile of grade 3 endo- metrioid endometrial carcinoma:is it a type I or type II eadometrial carcinoma[ J]. Am J Surg Pathol,2012,36 (5) :753 - 761.
  • 5Park JY, Nam JH, Kim YT, et al. Poor prognosis of uterine serous car- cinoma compared with grade 3 endometrioid carcinoma in early stage patients[ J]. Virchows Arch ,2013,462 (3) : 289 - 296.
  • 6Gadducci A, Cosio S, Landoni F, et al. Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma:a co- operation task force (CTF) study [ J ]. Int J Gynecol Cancer, 2012,22 (8) :1355 - 1360.
  • 7Reid-Nicholson M, Iyengar P, Hummer AJ, et al. Immunophenotypic diversity of endometria] adenoearcinomas : implications for differential diagnosis [ J ]. Mod Pathol, 2006,19 ( 8 ) : 1091 - 1100.
  • 8Fader AN, Boruta D, Olawaiye AB, et al. Uterine papillary serous car- cinoma : epidemiology, pathogenesis and management [ J ]. Curt" Opin Obstet Gyneco1,2010,22 ( 1 ) :21 - 29.
  • 9Dobrzycka B,Terlikowski SJ, Garbowicz M, et al. The prognostic signifi- cance of the immunohistochemical expression of P53 and BCL-2 in endo- metrial cancer[J]. Folia Histochem Cytobiol,2011,49(4) :631 -635.
  • 10Hamilton CA, Cheung MK, Osann K, et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3endometrioid corpus cancers [ J ]. Br J Cancer, 2006, 94 ( 5 ) : 642 - 646.

二级参考文献19

  • 1廖晓耘,王恩杰,吕晓红,李荣,沈丹华.子宫浆液性癌及内膜上皮内癌临床病理分析[J].临床与实验病理学杂志,2006,22(1):36-41. 被引量:4
  • 2Roelofsen T,van Ham MA,de Hullu JA. Clinical management of uterine papillary serous carcinoma[J].{H}EXPERT REVIEW OF ANTICANCER THERAPY,2011,(01):71-81.
  • 3杨越波;李小毛;向阳.子宫肿瘤[M]{H}北京:人民军医出版社,2012468-469.
  • 4Fader AN,Boruta D,Olawaiye AB. Uterine papillary serous carcinoma:epidemiology,pathogenesis and management[J].{H}Current Opinion in Obstetrics & Gynecology,2010,(01):21-29.
  • 5Moore KN,Fader AN. Uterine papillary serous carcinoma[J].{H}CLINICAL OBSTETRICS AND GYNECOLOGY,2011,(02):278-291.
  • 6Tergas AI,Buell-Gutbrod R,Gwin K. Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure[J].{H}Gynecologic Oncology,2012,(02):316-320.
  • 7Lavie O,Ben-Arie A,Segev Y. BRCA germline mutations in women with uterine serous carcinoma--still a debate[J].{H}International Journal of Gynecological Cancer,2010,(09):1531-1534.
  • 8Ambros RA,Sherman ME,Zahn CM. Endometrial intraepithelial carcinoma:a distinctive lesion specifically associated with tumors displaying serous differentiation[J].{H}Human Pathology,1995,(11):1260-1267.
  • 9Pathiraja P,Dhar S,Haldar K. Serous endometrial intraepithelial carcinoma:a case series and literature review[J].Cancer Manag Res,2013.117-122.
  • 10Yi X,Zheng W. Endometrial glandular dysplasia and endometrial intraepithelial neoplasia[J].{H}Current Opinion in Obstetrics & Gynecology,2008,(01):20-25.

共引文献1

同被引文献41

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部